Technical Analysis for SNPHY - Santen Pharmaceutical Co

Grade Last Price % Change Price Change
grade C 17.13 0.00% 0.0000
SNPHY closed unchanged on Monday, October 21, 2019, on 1.16 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical SNPHY trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
Fell Below 50 DMA Bearish 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Crossed Above 50 DMA Bullish -1.30%
Narrow Range Bar Range Contraction -1.30%
Fell Below 50 DMA Bearish -0.70%

Older signals for SNPHY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Santen Pharmaceutical Co., Ltd. researches and develops, produces, and markets pharmaceuticals and medical devices in Japan and internationally. It offers prescription pharmaceutical products for glaucoma and ocular hypertension, dry eyes, allergic conjunctivitis, severe keratitis with dry eyes, vernal keratoconjunctivitis, uveitis, wet age-related macular degeneration, and myopia; and over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Medicine Health RTT Medical Specialties Glaucoma Conjunctivitis Over The Counter Pharmaceutical Products Wet Age Related Macular Degeneration Allergic Conjunctivitis Prescription Pharmaceutical Products Markets Pharmaceuticals Myopia Ocular Hypertension Pharmaceuticals And Medical Devices Keratoconjunctivitis Santen Pharmaceutical Severe Keratitis Uveitis Vernal Keratoconjunctivitis
Is SNPHY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 18.21
52 Week Low 12.76
Average Volume 6,979
200-Day Moving Average 15.6802
50-Day Moving Average 17.2765
20-Day Moving Average 17.3211
10-Day Moving Average 17.2447
Average True Range 0.2456
ADX 10.1
+DI 31.168
-DI 33.8938
Chandelier Exit (Long, 3 ATRs ) 17.4732
Chandelier Exit (Short, 3 ATRs ) 17.5368
Upper Bollinger Band 17.8495
Lower Bollinger Band 16.7927
Percent B (%b) 0.32
BandWidth 6.101229
MACD Line -0.0305
MACD Signal Line -0.0051
MACD Histogram -0.0254
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.5950
Resistance 3 (R3) 17.6333 17.5167 17.5175
Resistance 2 (R2) 17.5167 17.3982 17.4975 17.4916
Resistance 1 (R1) 17.3233 17.3251 17.2650 17.2850 17.4658
Pivot Point 17.2067 17.2067 17.1775 17.1875 17.2067
Support 1 (S1) 17.0133 17.0882 16.9550 16.9750 16.7942
Support 2 (S2) 16.8967 17.0151 16.8775 16.7684
Support 3 (S3) 16.7033 16.8967 16.7425
Support 4 (S4) 16.6650